Contact this trialFirst, we need to learn more about you.
Anti-metabolites
NALIRIFOX for Small Bowel Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial involves giving a combination of different medications through an IV to patients on an outpatient basis. The treatment will be given on Day 1 and Day 15 of each 28-day cycle for up
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service